\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\ decreased\\ hematocrit\\.\ \(0\)\
\-\ surgical\\ resection\\ with\\ whipple\\'s\\ procedure\\.\\ \\ with\\ extensive\\ hepatic\\ metastases\\,\\ prognosis\\ is\\ poor\\.\ \(0\)\
\-\ small\\ bowel\\ follow\\-through\\ fluoroscopic\\ exam\\ with\\ spot\\ compression\\ images\\ display\\ a\\ focal\\ area\\ of\\ concentric\\ narrowing\\ with\\ abrupt\\ shouldering\\ located\\ within\\ the\\ distal\\ 3rd\\ portion\\ of\\ the\\ duodenum\\.\ \(0\)\
\-\ oral\\ and\\ iv\\ contrast\\ enhanced\\ ct\\ of\\ abd\\/pelvis\\ demonstrates\\ a\\ 4x2\\ cm\\ mass\\ and\\ indistinct\\ thickening\\ of\\ the\\ 3rd\\ and\\ 4th\\ portions\\ of\\ the\\ duodenum\\ with\\ surrounding\\ enlarged\\,\\ pathologic\\ lymph\\ nodes\\.\\ \\ also\\,\\ multiple\\ indistinct\\,\\ large\\ hypoattenuating\\ lesions\\ are\\ present\\ throughout\\ the\\ liver\\.\ \(0\)\
\-\ metastatic\\ pancreatic\\ adenocarcinoma\ \(0\)\
\-\ 1\\.\\ adenocarcinoma\ \(0\)\
\-\ 2\\.\\ carcinoid\ \(0\)\
\-\ 3\\.\\ leiomyosarcoma\ \(0\)\
\-\ 4\\.\\ metastases\ \(0\)\
\-\ 5\\.\\ lymphoma\ \(0\)\
\-\ 6\\.\\ duodenitis\ \(0\)\
\-\ 7\\.\\ ibd\ \(0\)\
\-\ 1\\.\\ melena\\ with\\ no\\ source\\ discovered\\ via\\ egd\\ or\\ colonoscopy\\.\ \(0\)\
\-\ 2\\.\\ decreased\\ appetite\\.\ \(0\)\
\-\ 3\\.\\ generalized\\ weakness\\.\ \(0\)\
\-\ types\\ of\\ small\\ bowel\\ malignancy\\ include\\ adenocarcinoma\\,\\ carcinoid\\,\\ lymphoma\\,\\ leiomyosarcoma\\ and\\ metastases\\.\\ the\\ most\\ common\\ small\\ bowel\\ malignancy\\ is\\ carcinoid\\.\\ \\ no\\ findings\\,\\ including\\ desmoplastic\\ reaction\\ of\\ the\\ mesentery\\,\\ are\\ seen\\ in\\ this\\ case\\.\ \(0\)\
\-\ primary\\ adenocarcinoma\\ of\\ the\\ small\\ bowel\\ is\\ a\\ rare\\ entity\\ accounting\\ for\\ less\\ than\\ 1\\%\\ of\\ all\\ primary\\ gi\\ malignancies\\.\\ \\ \ \(0\)\
\-\ the\\ most\\ common\\ location\\ of\\ adenocarcinoma\\ to\\ occur\\ in\\ small\\ bowel\\ is\\ within\\ the\\ duodenum\\.\\ \\ \ \(0\)\
\-\ barium\\ studies\\ and\\ ct\\ can\\ both\\ be\\ helpful\\ for\\ detecting\\ small\\ bowel\\ adenocarcinoma\\.\\ \ \(0\)\
\-\ pancreatic\\ carcinoma\\ can\\,\\ as\\ in\\ this\\ case\\,\\ affect\\ the\\ small\\ bowel\\ by\\ direct\\ extension\\ or\\ through\\ metastasis\\.\\ it\\ is\\ also\\ a\\ type\\ of\\ adenocarcioma\\.\\ \\ prognosis\\ is\\ poor\\ with\\ a\\ mean\\ survival\\ rate\\ of\\ 8\\%\\ at\\ one\\ year\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.08264674129619191\ \(0\)\
\-\ bowel\\:\\ 0\\.06999878630669147\ \(0\)\
\-\ carcinoid\\:\\ 0\\.056841591108393236\ \(0\)\
\-\ duodenum\\:\\ 0\\.051782056141120206\ \(0\)\
\-\ small\\:\\ 0\\.05141801115920832\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.04207063129566083\ \(0\)\
\-\ indistinct\\:\\ 0\\.04176598954550968\ \(0\)\
\-\ metastases\\:\\ 0\\.04086640802286923\ \(0\)\
\-\ 4x2\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ duodenitis\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ adenocarcioma\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ 3rd\\:\\ 0\\.031571275711163624\ \(0\)\
\-\ pancreatic\\:\\ 0\\.031199921162215392\ \(0\)\
\-\ prognosis\\:\\ 0\\.030248839471408523\ \(0\)\
\-\ 1\\.\\:\\ 0\\.02987898320482389\ \(0\)\
\-\ poor\\:\\ 0\\.028699291973063413\ \(0\)\
\-\ follow\\-through\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ abd\\/pelvis\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ whipple\\:\\ 0\\.025134615232412918\ \(0\)\
\-\ shouldering\\:\\ 0\\.024695126293396562\ \(0\)\
\-\ malignancy\\:\\ 0\\.024642460282100865\ \(0\)\
\-\ desmoplastic\\:\\ 0\\.02362168572454663\ \(0\)\
\-\ melena\\:\\ 0\\.023323018904869257\ \(0\)\
\-\ display\\:\\ 0\\.022548245155696704\ \(0\)\
\-\ ibd\\:\\ 0\\.022548245155696704\ \(0\)\
\-\ 3\\.\\:\\ 0\\.02181995680702035\ \(0\)\
\-\ egd\\:\\ 0\\.02171561996422577\ \(0\)\
\-\ accounting\\:\\ 0\\.02171561996422577\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.021533567112847294\ \(0\)\
\-\ concentric\\:\\ 0\\.021359984964955902\ \(0\)\
\-\ detecting\\:\\ 0\\.021035315647830417\ \(0\)\
\-\ malignancies\\:\\ 0\\.020329188783507552\ \(0\)\
\-\ 2\\.\\:\\ 0\\.02027943389403178\ \(0\)\
\-\ mean\\:\\ 0\\.01984705545708962\ \(0\)\
\-\ abrupt\\:\\ 0\\.019735663803546032\ \(0\)\
\-\ mesentery\\:\\ 0\\.019522386139964137\ \(0\)\
\-\ entity\\:\\ 0\\.019522386139964137\ \(0\)\
\-\ decreased\\:\\ 0\\.01896086867704895\ \(0\)\
\-\ primary\\:\\ 0\\.01889092733504251\ \(0\)\
\-\ hematocrit\\:\\ 0\\.01877361488823969\ \(0\)\
\-\ appetite\\:\\ 0\\.018689760948493204\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.018607750102527625\ \(0\)\
\-\ affect\\:\\ 0\\.018372007932298026\ \(0\)\
\-\ lymphoma\\:\\ 0\\.018225362943205117\ \(0\)\
\-\ fluoroscopic\\:\\ 0\\.017434267528264796\ \(0\)\
\-\ spot\\:\\ 0\\.017149293726829818\ \(0\)\
\-\ survival\\:\\ 0\\.017094820594661338\ \(0\)\
\-\ 7\\.\\:\\ 0\\.01698820353330292\ \(0\)\
\-\ source\\:\\ 0\\.01683378108493406\ \(0\)\
\-\ common\\:\\ 0\\.016688561283256693\ \(0\)\
\-\ generalized\\:\\ 0\\.01668549627654035\ \(0\)\
\-\ portions\\:\\ 0\\.016589815565296553\ \(0\)\
\-\ helpful\\:\\ 0\\.016496527124231563\ \(0\)\
\-\ types\\:\\ 0\\.01627302659594399\ \(0\)\
\-\ 4th\\:\\ 0\\.016062160139737495\ \(0\)\
\-\ discovered\\:\\ 0\\.015710254619322413\ \(0\)\
\-\ 6\\.\\:\\ 0\\.015492833320352355\ \(0\)\
\-\ barium\\:\\ 0\\.015457796975763402\ \(0\)\
\-\ direct\\:\\ 0\\.01506117511513048\ \(0\)\
\-\ \\%\\:\\ 0\\.014875530099597072\ \(0\)\
\-\ most\\:\\ 0\\.014722650311403553\ \(0\)\
\-\ reaction\\:\\ 0\\.014481509294163456\ \(0\)\
\-\ can\\:\\ 0\\.01446434591394828\ \(0\)\
\-\ nodes\\:\\ 0\\.014401833456586707\ \(0\)\
\-\ gi\\:\\ 0\\.014323823438604192\ \(0\)\
\-\ pathologic\\:\\ 0\\.013956509734077131\ \(0\)\
\-\ case\\:\\ 0\\.013951525618412468\ \(0\)\
\-\ 5\\.\\:\\ 0\\.013752312347176958\ \(0\)\
\-\ via\\:\\ 0\\.01368665651922778\ \(0\)\
\-\ enhanced\\:\\ 0\\.01364351912220884\ \(0\)\
\-\ oral\\:\\ 0\\.013435009949095196\ \(0\)\
\-\ procedure\\:\\ 0\\.013354762914688616\ \(0\)\
\-\ hepatic\\:\\ 0\\.013315277432111985\ \(0\)\
\-\ located\\:\\ 0\\.0131238845426062\ \(0\)\
\-\ lymph\\:\\ 0\\.01287142689904719\ \(0\)\
\-\ narrowing\\:\\ 0\\.012785248858768647\ \(0\)\
\-\ extensive\\:\\ 0\\.012751327322569945\ \(0\)\
\-\ is\\:\\ 0\\.012588599516075947\ \(0\)\
\-\ also\\:\\ 0\\.012571788012463815\ \(0\)\
\-\ 4\\.\\:\\ 0\\.012554029740301485\ \(0\)\
\-\ rate\\:\\ 0\\.012428065262969563\ \(0\)\
\-\ rare\\:\\ 0\\.012381903726392895\ \(0\)\
\-\ within\\:\\ 0\\.012165159764075235\ \(0\)\
\-\ occur\\:\\ 0\\.011962860555154994\ \(0\)\
\-\ compression\\:\\ 0\\.011935624351865399\ \(0\)\
\-\ throughout\\:\\ 0\\.011935624351865399\ \(0\)\
\-\ metastasis\\:\\ 0\\.011935624351865399\ \(0\)\
\-\ 8\\:\\ 0\\.011922080441228911\ \(0\)\
\-\ studies\\:\\ 0\\.011908585514101342\ \(0\)\
\-\ weakness\\:\\ 0\\.01184183340682233\ \(0\)\
\-\ iv\\:\\ 0\\.011635913945750349\ \(0\)\
\-\ portion\\:\\ 0\\.011549278534921964\ \(0\)\
\-\ including\\:\\ 0\\.011512756123107924\ \(0\)\
\-\ extension\\:\\ 0\\.01138181836261811\ \(0\)\
\-\ location\\:\\ 0\\.011122043607850346\ \(0\)\
\-\ \\,\\:\\ 0\\.011111234032425974\ \(0\)\
\-\ liver\\:\\ 0\\.01099336384639076\ \(0\)\
\-\ enlarged\\:\\ 0\\.010879183098447785\ \(0\)\
\-\ thickening\\:\\ 0\\.010808300633184147\ \(0\)\
\-\ less\\:\\ 0\\.010798283598218964\ \(0\)\
\-\ type\\:\\ 0\\.010748597866966083\ \(0\)\
\-\ surrounding\\:\\ 0\\.010481959941659572\ \(0\)\
\-\ area\\:\\ 0\\.010081478522889056\ \(0\)\
\-\ resection\\:\\ 0\\.009943715132538129\ \(0\)\
\-\ focal\\:\\ 0\\.009106319418426873\ \(0\)\
\-\ through\\:\\ 0\\.009055809770227121\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009037043544835323\ \(0\)\
\-\ all\\:\\ 0\\.009018371229221235\ \(0\)\
\-\ include\\:\\ 0\\.00894460256727719\ \(0\)\
\-\ ct\\:\\ 0\\.008920176517851066\ \(0\)\
\-\ are\\:\\ 0\\.008693088600967177\ \(0\)\
\-\ distal\\:\\ 0\\.008668949958753832\ \(0\)\
\-\ one\\:\\ 0\\.008640788743696433\ \(0\)\
\-\ cm\\:\\ 0\\.00855207506648129\ \(0\)\
\-\ lesions\\:\\ 0\\.008535673531134134\ \(0\)\
\-\ than\\:\\ 0\\.008354659906411469\ \(0\)\
\-\ both\\:\\ 0\\.008142537278679557\ \(0\)\
\-\ metastatic\\:\\ 0\\.008026527625433173\ \(0\)\
\-\ 1\\:\\ 0\\.0075870386864168166\ \(0\)\
\-\ or\\:\\ 0\\.007474050365400802\ \(0\)\
\-\ a\\:\\ 0\\.007399250033929127\ \(0\)\
\-\ present\\:\\ 0\\.0072015252012376145\ \(0\)\
\-\ this\\:\\ 0\\.007172665771000993\ \(0\)\
\-\ it\\:\\ 0\\.0071673447184067785\ \(0\)\
\-\ contrast\\:\\ 0\\.007137222711969796\ \(0\)\
\-\ \\'s\\:\\ 0\\.007030024695399421\ \(0\)\
\-\ exam\\:\\ 0\\.007004604253543052\ \(0\)\
\-\ large\\:\\ 0\\.0069721732531010435\ \(0\)\
\-\ demonstrates\\:\\ 0\\.006965004483780545\ \(0\)\
\-\ findings\\:\\ 0\\.006786704984290894\ \(0\)\
\-\ multiple\\:\\ 0\\.0067156940428330925\ \(0\)\
\-\ surgical\\:\\ 0\\.006702320038251692\ \(0\)\
\-\ no\\:\\ 0\\.0064212250052522535\ \(0\)\
\-\ seen\\:\\ 0\\.0063008493099540675\ \(0\)\
\-\ images\\:\\ 0\\.006116656313243859\ \(0\)\
\-\ the\\:\\ 0\\.005674410939327925\ \(0\)\
\-\ for\\:\\ 0\\.005441105586885934\ \(0\)\
\-\ by\\:\\ 0\\.005309219788227145\ \(0\)\
\-\ of\\:\\ 0\\.005216588095432318\ \(0\)\
\-\ be\\:\\ 0\\.004917002699044512\ \(0\)\
\-\ as\\:\\ 0\\.004823050395127342\ \(0\)\
\-\ in\\:\\ 0\\.004717133173211809\ \(0\)\
\-\ mass\\:\\ 0\\.004434555996073002\ \(0\)\
\-\ at\\:\\ 0\\.004320011764297138\ \(0\)\
\-\ year\\:\\ 0\\.0035675569748989354\ \(0\)\
\-\ and\\:\\ 0\\.0033583769726160157\ \(0\)\
\-\ with\\:\\ 0\\.0030560792262284632\ \(0\)\
\-\ \\.\\:\\ 0\\.0023842972005680336\ \(0\)\
\-\ to\\:\\ 0\\.0015935377180708442\ \(0\)\
